silver has been researched along with oseltamivir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, L; Li, Y; Lin, Z; Wang, C; Wang, H; Xia, H; Xu, T; Zhao, M; Zhu, B | 1 |
| Chang, SY; Chao, TL; Cheng, TR; Chiu, CL; Fang, JM; Huang, HC; Huang, KY; Kao, HC; Lu, L; Pang, YH; Yang, PC | 1 |
2 other study(ies) available for silver and oseltamivir
| Article | Year |
|---|---|
Silver Nanoparticle Based Codelivery of Oseltamivir to Inhibit the Activity of the H1N1 Influenza Virus through ROS-Mediated Signaling Pathways.
Topics: Animals; Antiviral Agents; Dogs; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Metal Nanoparticles; Oseltamivir; Reactive Oxygen Species; Silver | 2016 |
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses.
Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Drug Resistance, Viral; Food Additives; Gold; HEK293 Cells; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Metal Nanoparticles; Nanocomposites; Oseltamivir; Particle Size; Protein Binding; SARS-CoV-2; Silver; Spike Glycoprotein, Coronavirus; Virus Internalization; Zinc Oxide | 2021 |